menu
    • menu

    Company profile for Phoenix Biotechnology

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Phoenix Biotechnology, Inc., has been exploring the health-related benefits of a novel extract of Nerium oleander for the past 20 years. The company has developed a supercritical CO2 extraction of Nerium oleander into a new botanical drug – PBI-05204. PBI-05204 is a ‘botanical drug’ that has been through initial FDA review and approved for the Phase I and Phase II clinical trials which were conducted in the United Sta...
    Phoenix Biotechnology, Inc., has been exploring the health-related benefits of a novel extract of Nerium oleander for the past 20 years. The company has developed a supercritical CO2 extraction of Nerium oleander into a new botanical drug – PBI-05204. PBI-05204 is a ‘botanical drug’ that has been through initial FDA review and approved for the Phase I and Phase II clinical trials which were conducted in the United States. These trials have shown that this oral (capsule) formulation is safe for administration to patients without undue toxicity.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Phoenix BiotechnologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Phoenix Biotechnology, Inc. 8626 Tesoro Dr. Suite 801 San Antonio, TX 78217
    Telephone
    Telephone
    (210) 828-4373
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.phoenixbiotechnology.com/index.php
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Intrinsic Medicine & Phoenix Biotech Mutually Agree to Terminate Agreement
    Intrinsic Medicine & Phoenix Biotech Mutually Agree to Terminate Agreement

    06 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2022/12/07/2568883/0/en/Intrinsic-Medicine-and-Phoenix-Biotech-Acquisition-Corp-Mutually-Agree-to-Terminate-Business-Combination-Agreement.html

    GLOBENEWSWIRE
    06 Dec 2022
    Share Share
    Intrinsic Medicine enters merger with Phoenix Biotech
    Intrinsic Medicine enters merger with Phoenix Biotech

    01 Nov 2022

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/intrinsic-medicine-merger-deal/

    PHARMACEUTICAL-TECHNOLOGY
    01 Nov 2022
    Share Share
    Intrinsic wanted an IPO. Instead, it's a SPAC for the gut-brain microbiome
    Intrinsic wanted an IPO. Instead, it's a SPAC for the gut-brain microbiome

    31 Oct 2022

    // Kyle LaHucik ENDPTS

    https://endpts.com/intrinsic-wanted-an-ipo-instead-its-a-spac-for-the-gut-brain-microbiome-biotech/

    Kyle LaHucik ENDPTS
    31 Oct 2022
    Share Share
    Phoenix Biotechnology, Inc Receives FDA Warning Letter
    Phoenix Biotechnology, Inc Receives FDA Warning Letter

    17 Dec 2020

    // FDA

    https://www.pharmacompass.com/pdf/news/phoenix-biotechnology-inc-receives-fda-warning-letter-1612780304.pdf

    FDA
    17 Dec 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search